Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes

Published:2016-07-02 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Bratton Daniel J.,Parmar Mahesh K. B.,Phillips Patrick P. J.,Choodari-Oskooei Babak

Funder

Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1382-5

Reference26 articles.

1. Royston P, Parmar MK, Qian W. Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer. Stat Med. 2003; 22(14):2239–56.

2. Royston P, Barthel FM, Parmar MK, Choodari-Oskooei B, Isham V. Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit. Trials. 2011; 12:81.

3. Bratton DJ, Phillips PPJ, Parmar MKB. A multi-arm multi-stage clinical trial design for binary outcomes with application to tuberculosis. Med Res Methodol. 2013; 13:139.

4. Parmar MK, Barthel FM, Sydes M, Langley R, Kaplan R, Eisenhauer E, et al.Speeding up the evaluation of new agents in cancer. J Natl Cancer Inst. 2008; 100(17):1204–14.

5. Phillips PPJ, Gillespie SH, Boeree M, Heinrich N, Aarnoutse R, McHugh T, et al.Innovative trial designs are practical solutions for improving the treatment of tuberculosis. J Infect Dis. 2012; 205(suppl 2):S250–7.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of alternative ranking methods in two-stage clinical trials with multiple interventions: An application to the anxiolysis for laceration repair in children trial;Clinical Trials;2024-05-21

2. Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple Endpoints;Statistics in Biopharmaceutical Research;2024-05-17

3. Optimal sample size division in two‐stage seamless designs;Pharmaceutical Statistics;2024-04-27

4. Facilities for optimizing and designing multiarm multistage (MAMS) randomized controlled trials with binary outcomes;The Stata Journal: Promoting communications on statistics and Stata;2023-09

5. Group-sequential response-adaptive designs for multi-armed trials;Sequential Analysis;2023-04-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3